Literature DB >> 24715632

Dehydroepiandrosterone sulfate levels in Turkish obese patients.

Senay Topsakal1, Fulya Akin, Emrah Yerlikaya, Tuba Erurker, Hilmi Dogu.   

Abstract

PURPOSE: Obesity is well known to be linked to higher morbidity and mortality. Elevated plasma levels of free dehydroepiandrosterone (DHEA) are associated with reduced obesity and more limited accumulation of abdominal body fat. In contrast, the relationship between the DHEA sulfate ester (DHEAS) and adiposity is inconsistent and contradictory.
METHODS: The aim of this study was to compare DHEAS levels in obese Turkish individuals, 37 men and 246 women. A variety of fatness, hormone, and blood parameters were measured.
RESULTS: Statistically significant differences were found between male and female individuals with respect to weight, waist circumference, fat %, insulin, and DHEAS levels.
CONCLUSIONS: We found that in the Turkish population, while a correlation between obesity parameters and DHEAS levels exists in both female and male individuals, DHEAS levels are significantly higher in obese male individuals than in obese female individuals.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24715632     DOI: 10.1007/s40519-014-0120-9

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   4.652


  30 in total

Review 1.  Androgens and aging men.

Authors:  Etienne-Emile Baulieu
Journal:  Mol Cell Endocrinol       Date:  2002-12-30       Impact factor: 4.102

Review 2.  Stress responses and innate immunity: aging as a contributory factor.

Authors:  Stephen K Butcher; Janet M Lord
Journal:  Aging Cell       Date:  2004-08       Impact factor: 9.304

Review 3.  The biological actions of dehydroepiandrosterone involves multiple receptors.

Authors:  Stephanie J Webb; Thomas E Geoghegan; Russell A Prough; Kristy K Michael Miller
Journal:  Drug Metab Rev       Date:  2006       Impact factor: 4.518

Review 4.  Dehydroepiandrosterone--a neurosteroid.

Authors:  E Friess; T Schiffelholz; T Steckler; A Steiger
Journal:  Eur J Clin Invest       Date:  2000-12       Impact factor: 4.686

5.  Cortisol, DHEAS, their ratio and the metabolic syndrome: evidence from the Vietnam Experience Study.

Authors:  Anna C Phillips; Douglas Carroll; Catharine R Gale; Janet M Lord; Wiebke Arlt; G David Batty
Journal:  Eur J Endocrinol       Date:  2010-02-17       Impact factor: 6.664

6.  The association between dehydroepiandosterone and frailty in older men and women.

Authors:  M Voznesensky; S Walsh; D Dauser; J Brindisi; A M Kenny
Journal:  Age Ageing       Date:  2009-03-09       Impact factor: 10.668

Review 7.  Dehydroepiandrosterone - is the fountain of youth drying out?

Authors:  P Celec; L Stárka
Journal:  Physiol Res       Date:  2003       Impact factor: 1.881

8.  Dehydroepiandrosterone inhibits B16 mouse melanoma cell growth by induction of differentiation.

Authors:  S Kawai; N Yahata; S Nishida; K Nagai; Y Mizushima
Journal:  Anticancer Res       Date:  1995 Mar-Apr       Impact factor: 2.480

9.  Dehydroepiandrosterone sulfate (DHEAS) and health: does the relationship differ by sex?

Authors:  Dana A Glei; Noreen Goldman; Maxine Weinstein; I-Wen Liu
Journal:  Exp Gerontol       Date:  2004-03       Impact factor: 4.032

10.  Obesity, disease, and functional limitation in later life.

Authors:  C L Himes
Journal:  Demography       Date:  2000-02
View more
  2 in total

1.  Relationship between serum DHEAS and oxidative stress levels of body mass index in healthy postmenopausal women.

Authors:  Burhan Goy; Murat Atmaca; Mehmet Aslan; Rıfkı Ucler; Murat Alay; Ismet Seven; Halit Demir; Mustafa Ozturk
Journal:  Redox Rep       Date:  2016-02-23       Impact factor: 4.412

2.  Cross-Sectional Inverse Associations of Obesity and Fat Accumulation Indicators with Testosterone in Non-Diabetic Aging Men.

Authors:  Iwona Rotter; Aleksandra Rył; Katarzyna Grzesiak; Aleksandra Szylińska; Wioletta Pawlukowska; Anna Lubkowska; Olimpia Sipak-Szmigiel; Krzysztof Pabisiak; Maria Laszczyńska
Journal:  Int J Environ Res Public Health       Date:  2018-06-08       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.